Skip to content
HowShorted

CorMedix Inc. short interest in 2021

In 2021, CorMedix Inc.'s disclosed short interest ran from 9.48% of shares outstanding on 15 Jan 2021 to 4.83% on 31 Dec 2021, a change of -4.65 percentage points. The year's high was 9.74% on 29 Jan 2021 and its low 4.83% on 31 Dec 2021, averaging 6.53% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 12.11 days on 31 Aug 2021. Full history: CorMedix Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for CorMedix Inc. in 2021

2021 in figures

Start of year
9.48% (15 Jan 2021)
End of year
4.83% (31 Dec 2021)
Change
-4.65 pp
High
9.74% (29 Jan 2021)
Low
4.83% (31 Dec 2021)
Average
6.53%
Highest days to cover
12.11 (31 Aug 2021)
SEC filings marked
8

Every report in 2021

CorMedix Inc. short interest in 2021
SettlementShort interestDays to coverFilings since previous
15 Jan 20219.48%7.58
29 Jan 20219.74%7.05
12 Feb 20218.29%1.31
26 Feb 20218.23%1.86
15 Mar 20218.55%1.07
31 Mar 20216.91%4.9310-K filed, results (8-K)
15 Apr 20216.64%5.08
30 Apr 20216.82%8.06
14 May 20216.85%8.9110-Q filed, results (8-K)
28 May 20216.78%7.93
15 Jun 20216.66%8.89
30 Jun 20216.57%5.41
15 Jul 20216.42%10.26
30 Jul 20216.45%11.09
13 Aug 20216.06%9.7710-Q filed, results (8-K)
31 Aug 20215.12%12.11
15 Sep 20215.35%4.27
30 Sep 20215.16%11.77
15 Oct 20215.29%11.77
29 Oct 20215.16%9.17
15 Nov 20215.12%7.0210-Q filed, results (8-K)
30 Nov 20215.08%10.88
15 Dec 20215.18%10.48
31 Dec 20214.83%8.55

See also: CorMedix Inc.'s full history · most shorted US stocks of 2021 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.